X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
index medicus (85) 85
oncology (85) 85
male (60) 60
female (55) 55
carcinoma, renal cell - drug therapy (54) 54
middle aged (54) 54
cancer (53) 53
kidney neoplasms - drug therapy (49) 49
metastasis (48) 48
sunitinib (48) 48
aged (47) 47
treatment outcome (39) 39
antineoplastic agents - therapeutic use (37) 37
adult (35) 35
kidney neoplasms - pathology (33) 33
care and treatment (29) 29
interferon-alpha (29) 29
carcinoma, renal cell (28) 28
everolimus (28) 28
renal cell carcinoma (28) 28
urology & nephrology (27) 27
sorafenib (26) 26
carcinoma, renal cell - pathology (25) 25
disease-free survival (24) 24
survival (24) 24
carcinoma, renal cell - secondary (23) 23
urology (21) 21
aged, 80 and over (20) 20
hematology, oncology and palliative medicine (20) 20
neoplasm metastasis (20) 20
targeted therapy (20) 20
antineoplastic agents - adverse effects (19) 19
kidney cancer (19) 19
medicine & public health (19) 19
prognosis (19) 19
protein kinase inhibitors - therapeutic use (19) 19
retrospective studies (18) 18
sirolimus - analogs & derivatives (18) 18
stem cells (17) 17
analysis (16) 16
carcinoma, renal cell - mortality (16) 16
clinical trials (16) 16
chemotherapy (15) 15
patients (15) 15
protein kinase inhibitors - adverse effects (15) 15
sirolimus - therapeutic use (15) 15
kaplan-meier estimate (14) 14
kidney neoplasms - mortality (14) 14
medical colleges (14) 14
tumors (14) 14
tyrosine (14) 14
metastases (13) 13
transplantation (13) 13
tyrosine kinase inhibitor (13) 13
vascular endothelial growth factor (13) 13
antineoplastic agents - administration & dosage (12) 12
drug administration schedule (12) 12
research (12) 12
safety (12) 12
survival analysis (12) 12
survival rate (12) 12
therapy (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
disease progression (11) 11
efficacy (11) 11
further section · weitere sektionen (11) 11
molecular targeted therapy (11) 11
risk factors (11) 11
time factors (11) 11
carcinoma (10) 10
clear cell-type renal cell carcinoma (10) 10
drug therapy (10) 10
niacinamide - analogs & derivatives (10) 10
nivolumab (10) 10
patient outcomes (10) 10
phase-iii trial (10) 10
angiogenesis inhibitors - therapeutic use (9) 9
animals (9) 9
antimitotic agents (9) 9
antineoplastic agents (9) 9
bevacizumab (9) 9
immunotherapy (9) 9
indoles - therapeutic use (9) 9
neoplasm staging (9) 9
open-label (9) 9
phase-ii (9) 9
protein kinase inhibitors - administration & dosage (9) 9
pyrroles - therapeutic use (9) 9
receptors, vascular endothelial growth factor - antagonists & inhibitors (9) 9
risk assessment (9) 9
temsirolimus (9) 9
cancer therapies (8) 8
carcinoma, renal cell - metabolism (8) 8
kidney neoplasms - metabolism (8) 8
medical prognosis (8) 8
mtor (8) 8
neoplasms - drug therapy (8) 8
performing operations (8) 8
quality of life (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 2019, Volume 42, Issue 3, pp. 150 - 150
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1233 - 1242
Journal Article
2002, Current problems in cancer, Volume 26, no. 3., 111-
Book
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 428 - 429
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 286 - 296
Journal Article
Der Onkologe, ISSN 0947-8965, 03/2019, Volume 25, Issue 3, pp. 232 - 239
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1045 - 1052
Journal Article
Der Onkologe, ISSN 0947-8965, 03/2019, Volume 25, Issue 3, p. 232
Hintergrund Es erfolgte eine Literaturrecherche zur Systemtherapie des RM-SCCHN. The systemic treatment of recurrent or metastatic squamous cell carcinoma of... 
Squamous cell carcinoma | Epidermal growth factor | Immunotherapy | Adjuvant treatment | Metastasis | Drug therapy | Cancer
Journal Article
Nature Reviews Nephrology, ISSN 1759-5061, 07/2018, Volume 14, Issue 10, pp. 1 - 2
Cytoreductive nephrectomy is the current treatment paradigm for metastatic renal cell carcinoma (RCC). However, the introduction of targeted therapies has... 
SURVIVAL | SUNITINIB | UROLOGY & NEPHROLOGY | CYTOREDUCTIVE NEPHRECTOMY | THERAPY | Kidney Neoplasms - surgery | Carcinoma, Renal Cell | Sunitinib | Nephrectomy | Humans | Treatment outcome | Care and treatment | Usage | Prognosis | Analysis | Carcinoma, Renal cell | Risk factors | Metastasis
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9637, pp. 449 - 456
Journal Article
Trials, ISSN 1745-6215, 07/2016, Volume 17, Issue 1, p. 312
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1104 - 1115
Journal Article